氧化应激诱导的端粒不稳定性导致T细胞功能障碍在癌症中
Dayana B Rivadeneira1, Sanjana Thosar2, Kevin Quann3
1Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Immunity
|September 10, 2025
概括
癌症中功能障碍的T细胞由于氧化应激而损坏了端粒,而不是短端粒. 用抗氧化剂保护端粒可以恢复T细胞功能并改善癌症治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 瘤微环境 (TME) 通过代谢和免疫应激引起免疫细胞功能障碍.
- 氧化应激,特别是来自线粒体的氧化应激,可以导致DNA损伤,包括端粒.
研究的目的:
- 为了调查TME内的T细胞中端粒功能障碍的原因.
- 为了确定氧化应激诱导的端粒损伤是否会损害T细胞功能.
- 探索针对端粒保护的治疗策略.
主要方法:
- 化学光遗传学用于诱导线粒体或端粒体的局部活性氧物种 (ROS).
- 在T细胞中评估了端粒损伤和脆弱性.
- 测量了T细胞细胞因子的产生和功能.
- 评估了一个端粒局部化的ROS清理器 (GPX1) 的效果.
主要成果:
- 癌症中功能障碍的T细胞表现出受损的,而不是缩短的端粒,这表明氧化应激是原因.
- 在端粒中诱导的ROS导致DNA损伤和端粒脆弱性,损害T细胞细胞因子生产.
- 将GPX1定位到端粒减少了端粒脆弱性,并在瘤中增强了治疗性T细胞功能.
结论:
- 由氧化应激驱动的端粒损伤,有助于瘤微环境中的T细胞功能障碍.
- 用抗氧化剂准端粒保护可能是一个可行的策略,以保持T细胞功能.
- 保护端粒可以提高基于T细胞的癌症疗法的疗效.
更多相关视频
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
8.5K
06:07Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
1.0K
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
Psychoneuroimmunology: Diabetes and Cancer
462
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
462
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
